Akron, OH 的 非小細胞肺癌 臨床試驗
22 項針對 非小細胞肺癌 的研究正在 Akron（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · 距離 21 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Aultman Health Foundation, Canton · 距離 21 英里
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
招募中3 期
- Akron General Medical Center, Akron
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
招募中3 期
- Research Site, Canton · 距離 21 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Aultman North, North Canton · 距離 15 英里
- Aultman Massillon, Massillon · 距離 20 英里
- Aultman Orrville Hospital, Orrville · 距離 21 英里
- 還有 2 項
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- Aultman Hospital, Canton · 距離 21 英里
Pan-tumor MRD Study
招募中觀察性研究
- Gabrail Cancer Center, Canton · 距離 21 英里
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- Gabrail Cancer Center Research, Canton · 距離 21 英里
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
招募中2 期
- Gabrail Cancer Center, Canton · 距離 21 英里
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
招募中2/3 期
- Tricounty Hematology and Oncology - Massillon, Massillon · 距離 20 英里
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
招募中1/2 期
- Gabrail Cancer Center Research, Canton · 距離 21 英里
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
招募中3 期
- Gabrail Cancer Center, Canton · 距離 21 英里
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
招募中2 期
- Gabrail Cancer and Research Center, Canton · 距離 21 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Cleveland Clinic Mercy Hospital, Canton · 距離 21 英里
- Aultman Health Foundation, Canton · 距離 21 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Aultman Health Foundation, Canton · 距離 21 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Aultman Health Foundation, Canton · 距離 21 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Aultman Health Foundation, Canton · 距離 21 英里
GEMINI-NSCLC: NSCLC Biomarker Study
招募中觀察性研究
- Aultman Hospital, Canton · 距離 21 英里
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
招募中1 期
- Gabrail Cancer & Research Center, Canton · 距離 21 英里
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 138, Canton · 距離 21 英里
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
招募中1/2 期
- Gabrail Cancer Center Research, Canton · 距離 21 英里
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
招募中1/2 期
- Gabrail Cancer Research Center, Canton · 距離 21 英里
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
Akron 的其他研究
- 肺癌16 項研究
- 乳癌13 項研究
- 癌症（所有類型）13 項研究
- 前列腺癌9 項研究
- 轉移性癌症8 項研究
- 急性髓系白血病8 項研究
- 小細胞肺癌8 項研究
- 黑色素瘤8 項研究
- 大腸直腸癌8 項研究
- 脂肪性肝病7 項研究
- 精神分裂症6 項研究
- 中風6 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。